We have demonstrated using high-resolution genomic profiling coupled with analysis of tumour phenotypes that the development of a subset of sporadic breast tumours is similar to that of tumours derived from BRCA1- or BRCA2 germline mutation carriers. Here, BRCA1 is linked to breast neoplasm.